Heliyon (Sep 2020)

A mutation in the promoter region of BTK causes atypical XLA

  • María Bravo García-Morato,
  • Lucía del Pino Molina,
  • Juan Manuel Torres Canizales,
  • Teresa del Rosal Rabes,
  • Ana Méndez Echevarría,
  • Berta González Martínez,
  • Eduardo López-Granados,
  • Rebeca Rodríguez Pena

Journal volume & issue
Vol. 6, no. 9
p. e04914

Abstract

Read online

X-linked Agammaglobulinemia is a primary immunodeficiency caused by mutations in BTK, a tyrosine kinase essential for B lymphocytes differentiation. Patients usually have very low or absent B lymphocytes and are not able to develop humoral specific responses. Here we present a boy, diagnosed with XLA due to a mutation on the promoter region of the gene, whose phenotype is characterised by low percentage of B cells, hypogammaglobulinemia, oscillating neutropenia, antibodies responses to some antigens after vaccination and IgE-mediated allergy. Additional technology as flow cytometry was needed to demonstrate the pathological status of the variant. We focus on the idea that XLA should be suspected in males with B lymphopenia and hypogammaglobulinemia, even if they make humoral specific responses. We also highlight the importance of sequencing BTK's promoter region, as mutations on it can be disease-causing.

Keywords